Christina Zarrello03.27.07
The $5.4 billion world leader in medical technology, Stryker, has opened a global research and development centre in Gurgaon of Haryana to enhance their technology innovations and boot the commercial expansions in India.
The company, which spent 300 million dollar for R&D last year, has set up one of their key technology centres, first of its such centre in the Asia Pacific region, and it will have facilities for all products under innovation, Stryker president and chief executive officer Stephen P MacMillan told Pharmabiz.
"We have 20 such technology centres in the Europe and US but most of them cater to specialised products. The Indian centre will have research on all products,'' he said.
The US-based company is the largest player in the global orthopedic market and is the 9th largest medical technology company in the world. Its products include implants used in joint replacement, trauma, cranimaxillofacial and spinal surgeries, biologics, surgical, neurologic, ear, nose & throat and interventional pain equipment, endoscopic, surgical navigation and digital imaging systems.
MacMillan said India was evolving as a large market in medical devices and the company would enhance its commercial operations in the coming years. It launched operations in four metros in 2001 and will now expand the sales to over 20 markets by the end of this year.
The global centre in India has opened with 40 scientists to begin with and would add more talents in the next stages. Experts will be brought from the US to give rigorous training to the core talents available here on a regular basis, he said. It would also design prototypes of implants and would take into consideration the tastes and preferences of the local market.
Without disclosing the investment quantum of the company in India, he said the global expenditure on R&D by the company has recorded a double-digit growth always and the Indian centre would be one of the main hubs for them.
Focus areas for Stryker in India would be orthopaedic implants, operating room equipment, surgical navigation and communications, endoscopy and power instruments. It has tied up with distributors along with direct marketing.
Though the company denied immediate plans of opening up manufacturing facility in the country, MacMillan said the R&D centre would boot the commercial hopes of the company in India.
SOURCE: Pharmabiz.com
The company, which spent 300 million dollar for R&D last year, has set up one of their key technology centres, first of its such centre in the Asia Pacific region, and it will have facilities for all products under innovation, Stryker president and chief executive officer Stephen P MacMillan told Pharmabiz.
"We have 20 such technology centres in the Europe and US but most of them cater to specialised products. The Indian centre will have research on all products,'' he said.
The US-based company is the largest player in the global orthopedic market and is the 9th largest medical technology company in the world. Its products include implants used in joint replacement, trauma, cranimaxillofacial and spinal surgeries, biologics, surgical, neurologic, ear, nose & throat and interventional pain equipment, endoscopic, surgical navigation and digital imaging systems.
MacMillan said India was evolving as a large market in medical devices and the company would enhance its commercial operations in the coming years. It launched operations in four metros in 2001 and will now expand the sales to over 20 markets by the end of this year.
The global centre in India has opened with 40 scientists to begin with and would add more talents in the next stages. Experts will be brought from the US to give rigorous training to the core talents available here on a regular basis, he said. It would also design prototypes of implants and would take into consideration the tastes and preferences of the local market.
Without disclosing the investment quantum of the company in India, he said the global expenditure on R&D by the company has recorded a double-digit growth always and the Indian centre would be one of the main hubs for them.
Focus areas for Stryker in India would be orthopaedic implants, operating room equipment, surgical navigation and communications, endoscopy and power instruments. It has tied up with distributors along with direct marketing.
Though the company denied immediate plans of opening up manufacturing facility in the country, MacMillan said the R&D centre would boot the commercial hopes of the company in India.
SOURCE: Pharmabiz.com